Sanguisorba officinalis L. derived from herbal medicine prevents intestinal inflammation by inducing autophagy in macrophages
- PMID: 32561763
- PMCID: PMC7305163
- DOI: 10.1038/s41598-020-65306-4
Sanguisorba officinalis L. derived from herbal medicine prevents intestinal inflammation by inducing autophagy in macrophages
Abstract
Disturbed activation of autophagy is implicated in the pathogenesis of inflammatory bowel disease. Accordingly, several autophagy-related genes have been identified as Crohn's disease susceptibility genes. We screened the autophagy activators from a library including 3,922 natural extracts using a high-throughput assay system. The extracts identified as autophagy activators were administered to mice with 2% dextran sodium sulfate (DSS). Among the autophagy inducers, Sanguisorba officinalis L. (SO) suppressed DSS-induced colitis. To identify the mechanism by which SO ameliorates colitis, epithelial cell and innate myeloid cells-specific Atg7-deficient mice (Villin-cre; Atg7f/f and LysM-cre; Atg7f/f mice, respectively) were analyzed. SO-mediated inhibition of colitis was observed in Villin-cre; Atg7f/f mice. However, SO and a mixture of its components including catechin acid, ellagic acid, gallic acid, and ziyuglycoside II (Mix4) did not suppressed colitis in LysM-cre; Atg7f/f mice. In large intestinal macrophages (Mφ) of Atg7f/f mice, SO and Mix4 upregulated the expression of marker genes of anti-inflammatory Mφ including Arg1, Cd206, and Relma. However, these alterations were not induced in LysM-cre; Atg7f/f mice. These findings indicate that SO and its active components ameliorate DSS-induced colitis by providing intestinal Mφ with anti-inflammatory profiles via promotion of Atg7-dependent autophagy.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Artemisinin ameliorates intestinal inflammation by skewing macrophages to the M2 phenotype and inhibiting epithelial-mesenchymal transition.Int Immunopharmacol. 2021 Feb;91:107284. doi: 10.1016/j.intimp.2020.107284. Epub 2020 Dec 20. Int Immunopharmacol. 2021. PMID: 33359851
-
The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease.Int Immunopharmacol. 2016 Jan;30:74-84. doi: 10.1016/j.intimp.2015.11.031. Epub 2015 Dec 3. Int Immunopharmacol. 2016. PMID: 26655877
-
Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.Gut. 2006 Aug;55(8):1104-13. doi: 10.1136/gut.2005.081745. Epub 2006 Mar 17. Gut. 2006. PMID: 16547072 Free PMC article.
-
ATG4B/autophagin-1 regulates intestinal homeostasis and protects mice from experimental colitis.Autophagy. 2013 Aug;9(8):1188-200. doi: 10.4161/auto.24797. Epub 2013 May 8. Autophagy. 2013. PMID: 23782979 Free PMC article.
-
Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease.Ann N Y Acad Sci. 2017 Aug;1401(1):37-48. doi: 10.1111/nyas.13414. Ann N Y Acad Sci. 2017. PMID: 28891095 Review.
Cited by
-
Evaluation of Polyphenolic Composition and Antimicrobial Properties of Sanguisorba officinalis L. and Sanguisorba minor Scop.Plants (Basel). 2022 Dec 16;11(24):3561. doi: 10.3390/plants11243561. Plants (Basel). 2022. PMID: 36559673 Free PMC article.
-
A Comprehensive Review of Genus Sanguisorba: Traditional Uses, Chemical Constituents and Medical Applications.Front Pharmacol. 2021 Sep 20;12:750165. doi: 10.3389/fphar.2021.750165. eCollection 2021. Front Pharmacol. 2021. PMID: 34616302 Free PMC article. Review.
-
Unraveling the role of autophagy regulation in Crohn's disease: from genetic mechanisms to potential therapeutics.Adv Biotechnol (Singap). 2024 Mar 21;2(2):14. doi: 10.1007/s44307-024-00021-z. Adv Biotechnol (Singap). 2024. PMID: 39883213 Free PMC article. Review.
-
Sanguisorba officinalis L. Ameliorates Hepatic Steatosis and Fibrosis by Modulating Oxidative Stress, Fatty Acid Oxidation, and Gut Microbiota in CDAHFD-Induced Mice.Nutrients. 2023 Aug 29;15(17):3779. doi: 10.3390/nu15173779. Nutrients. 2023. PMID: 37686810 Free PMC article.
-
Integrated Network Pharmacology, Molecular Docking and Animal Experiment to Explore the Efficacy and Potential Mechanism of Baiyu Decoction Against Ulcerative Colitis by Enema.Drug Des Devel Ther. 2023 Nov 23;17:3453-3472. doi: 10.2147/DDDT.S432268. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 38024534 Free PMC article.
References
-
- Murakami, Y. et al. Estimated prevalence of ulcerative colitis and Crohn’s disease in Japan in 2014: an analysis of a nationwide survey. J Gastroenterol(In press) (2019). - PubMed
-
- Maaser C, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13:144–164. - PubMed
-
- Kawai S, et al. Indigo naturalis ameliorates murine dextran sodium sulfate-induced colitis via aryl hydrocarbon receptor activation. J Gastroenterol. 2017;52:904–919. - PubMed
-
- Naganuma M, et al. Efficacy of indigo naturalis in a multicenter randomized controlled trial of patients with ulcerative colitis. Gastroenterology. 2018;154:935–947. - PubMed
-
- Jang E, Inn KS, Jang YP, Lee KT, Lee JH. Phytotherapeutic Activities of Sanguisorba officinalis and its Chemical Constituents: A Review. Am J Chin Med. 2018;46:299–318. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous
